Serial Number 90279251
Registration 6761544
700

Registration Progress

Application Filed
Oct 26, 2020
Under Examination
Jan 4, 2022
Approved for Publication
Nov 9, 2021
Published for Opposition
Nov 9, 2021
Registered
Jun 14, 2022

Trademark Image

Basic Information

Serial Number
90279251
Registration Number
6761544
Filing Date
October 26, 2020
Registration Date
June 14, 2022
Published for Opposition
November 9, 2021
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 14, 2022
Registration
Registered
Classes
005 042 044

Rights Holder

LONGBOARD PHARMACEUTICALS, INC.

03
Address
4275 EXECUTIVE SQUARE, SUITE 950
LA JOLLA, CA 92037

Ownership History

Arena Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Arena Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

LONGBOARD PHARMACEUTICALS, INC.

New Owner After Publication #1
03
LA JOLLA, CA

LONGBOARD PHARMACEUTICALS, INC.

Original Registrant
03
LA JOLLA, CA

Legal Representation

Attorney
Maren C. Perry

USPTO Deadlines

Next Deadline
1050 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-06-14)
Due Date
June 14, 2028
Grace Period Ends
December 14, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Jun 17, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 17, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 17, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 17, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 17, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 14, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 14, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 10, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 8, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 5, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 5, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 5, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 5, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 5, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 4, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 4, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 2, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 18, 2022 IUAF S USE AMENDMENT FILED Loading...
Apr 18, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 25, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 25, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 25, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 4, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 9, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 20, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 1, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 3, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 3, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 3, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 4, 2021 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Mar 4, 2021 GPRA F PRIORITY ACTION E-MAILED Loading...
Mar 4, 2021 CPRA R PRIORITY ACTION WRITTEN Loading...
Mar 1, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 17, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 16, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 29, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system
First Use Anywhere: Mar 10, 2022
First Use in Commerce: Mar 10, 2022
Class 042
Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the fields of pharmaceutical preparations, clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine and clinical trials; research and development services in the fields of pharmaceuticals and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals; scientific research and development, namely, pharmaceutical discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development
First Use Anywhere: Oct 27, 2020
First Use in Commerce: Oct 27, 2020
Class 044
Providing medical information
First Use Anywhere: Mar 28, 2022
First Use in Commerce: Mar 28, 2022

Additional Information

Design Mark
The mark consists of three concentric stylized waves. The bottom of the waves are connected to a horizontal line.

Classification

International Classes
005 042 044